Luxury electric car manufacturer Lucid (NASDAQ:LCID) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 49.2% year on year to $234.5
Medical tech company Masimo (NASDAQ:MASI) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 9.4% year on year to $600.7
Traders are getting concerned about froth in the market, according to a new survey from Schwab.
Berkshire Hathaway's Class A shares have appreciated 3,999,494% since Warren Buffett took over the company in 1965.
Shares in Germany's Rheinmetall have soared 57% this year, while BAE Systems is up 17% and France's Thales has gained 22%.
With Hims & Hers' main source of growth set to be extinguished, Citi analysts said its full-year guidance appeared "aspirational."
Learn more about the pros and cons of money market funds vs. high-yield savings accounts, plus key features of these two popular savings solutions.
Americans will soon accept that high mortgage and interest rates are here to stay and stop delaying projects, Melius Research said.
Hospitality company Playa Hotels & Resorts (NASDAQ:PLYA) reported Q4 CY2024 results topping the market’s revenue expectations, but sales fell by 9.7%
Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.5% year on year to $1.09
